China’s experimental Covid-19 vaccine costs $60

Published October 18, 2020
A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. —Reuters/File
A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. —Reuters/File

BEIJING: A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60.

The eastern city of Jiaxing’s center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine candidate, called CoronaVac, will cost 200 yuan ($29.75) per dose and that vaccinations for key groups including medical professionals have begun.

Chinese authorities have to date not released pricing details for potential Covid-19 vaccines. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.

It was not clear if Jiaxing city’s pricing includes subsidies. The city’s CDC declined to comment.

Sinovac did not immediately respond to a request for comment. Its vaccine is in late stage trials in Brazil, Indonesia and Turkey, and the company has said that an interim analysis of Phase three trial data could come as early as November.

Bio Farma, a state-owned firm in Indonesia which has reached a deal for at least 40 million doses from Sinovac, said this week the vaccine will cost around 200,000 rupiah ($13.60) per dose when it becomes available in the southeast Asian country.

China has said that while reasonable profits for companies are permitted, Covid-19 vaccines should be priced close to cost.

China National Pharmaceutical Group (Sinopharm) said in August that a vaccine candidate developed by a unit may cost no more than 1,000 yuan ($148.80) for two shots. An official at China’s National Health Commission has said, however, the price will be lower.

Published in Dawn, October 18th, 2020

Opinion

Victim syndrome
Updated 27 Sep 2021

Victim syndrome

Narratives of victimhood are self-denigrating and disempowering and also undermine national confidence.

Editorial

Intra-party discord
Updated 28 Sep 2021

Intra-party discord

It remains unclear whether former prime minister Nawaz Sharif is on board with the efforts of his younger brother.
28 Sep 2021

Auto finance revisions

THE State Bank’s decision to revise its prudential regulations governing consumer financing to limit car sales is ...
28 Sep 2021

Karachi tax collection

THE Sindh government’s decision to collect two municipal taxes through electricity bills from consumers only in...
Phasing out coal
Updated 27 Sep 2021

Phasing out coal

Move affords Pakistan an opportunity to renegotiate its deals with Beijing to convert them into cheaper, clean energy projects.
27 Sep 2021

Poor online score

A RECENT report by Freedom House, the US-based watchdog that assesses democratic trends around the world, has placed...
27 Sep 2021

Child’s mental capacity

CONVERTING to another faith is one of the most consequential decisions an individual can make in their lifetime. It...